Scancell Holdings plc (LON:SCLP – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 13.56 ($0.17) and traded as low as GBX 8.78 ($0.11). Scancell shares last traded at GBX 8.83 ($0.11), with a volume of 316,892 shares changing hands.
Scancell Stock Performance
The company has a market cap of £85.25 million, a PE ratio of -917.10 and a beta of 0.35. The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of 61.41. The stock’s 50 day simple moving average is GBX 10.40 and its two-hundred day simple moving average is GBX 13.53.
Scancell (LON:SCLP – Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. As a group, research analysts anticipate that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.
Scancell Company Profile
Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Featured Stories
- Five stocks we like better than Scancell
- Overbought Stocks Explained: Should You Trade Them?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.